69 related articles for article (PubMed ID: 2634757)
21. Toxicological profile of a low molecular weight spleen peptide formulation used in supportive cancer therapy.
Hartleb M; Leuschner J
Arzneimittelforschung; 1997 Sep; 47(9):1047-51. PubMed ID: 9342421
[TBL] [Abstract][Full Text] [Related]
22. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
23. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
24. [Hypolipidemic activity of glycine and its derivatives].
Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
[TBL] [Abstract][Full Text] [Related]
25. [Animal models used for the evaluation of anti-osteoarthritis drugs].
Smith MM; Little CB; Rodgers K; Ghosh P
Pathol Biol (Paris); 1997 Apr; 45(4):313-20. PubMed ID: 9296080
[TBL] [Abstract][Full Text] [Related]
26. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
27. [A preclinical study on the safety of a new antialcoholic drug inmecarb].
Liubimov BI; Smol'nikova Nm; Iavorskii AN; Strekalova SN; Boiko SS
Farmakol Toksikol; 1987; 50(6):80-2. PubMed ID: 3436433
[TBL] [Abstract][Full Text] [Related]
28. Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
Butler EG; England PJ; Williams GM
Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):125-8. PubMed ID: 3381006
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of a human-specific peroxisome proliferater-activated receptor alpha (PPARalpha) agonist in dogs.
Nagasawa M; Ide T; Suzuki M; Tsunoda M; Akasaka Y; Okazaki T; Mochizuki T; Murakami K
Biochem Pharmacol; 2004 Jun; 67(11):2057-69. PubMed ID: 15135303
[TBL] [Abstract][Full Text] [Related]
30. An investigation of leptospirosis in a laboratory animal house.
Natrajaseenivasan K; Ratnam S
J Commun Dis; 1996 Sep; 28(3):153-7. PubMed ID: 8973012
[TBL] [Abstract][Full Text] [Related]
31. Aflatoxin risks and control measures.
Wogan GN
Fed Proc; 1968; 27(3):932-8. PubMed ID: 4297624
[No Abstract] [Full Text] [Related]
32. Occupational allergy to laboratory animals: employer practices.
Lutsky II; Kalbfleisch JH; Fink JN
J Occup Med; 1983 May; 25(5):372-6. PubMed ID: 6854426
[TBL] [Abstract][Full Text] [Related]
33. [Nutrition of laboratory animals in breeding and in experiments. II. Recommended components in standard and special diets for mice, rats, hamsters, guinea pigs, rabbits, dogs, cats and monkeys].
Weik H; Drepper K
Z Versuchstierkd; 1970; 12(6):379-83. PubMed ID: 4994583
[No Abstract] [Full Text] [Related]
34. [Studies on the species-specificity of human blood. II. The "serum-hemoglobin-precipitation" reaction between animal blood and betweenhuman and animal blood].
Kimura S
Nihon Hoigaku Zasshi; 1967 Jan; 21(1):87-94. PubMed ID: 4962515
[No Abstract] [Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Primidone (CAS No. 125-33-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Sep; 476():1-290. PubMed ID: 12571687
[TBL] [Abstract][Full Text] [Related]
36. (2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents.
Koyama H; Boueres JK; Miller DJ; Berger JP; MacNaul KL; Wang PR; Ippolito MC; Wright SD; Agrawal AK; Moller DE; Sahoo SP
Bioorg Med Chem Lett; 2005 Jul; 15(14):3347-51. PubMed ID: 15950464
[TBL] [Abstract][Full Text] [Related]
37. Hypolipidemic activity of tincture of Crataegus in rats.
Shanthi S; Parasakthy K; Deepalakshmi PD; Devaraj SN
Indian J Biochem Biophys; 1994 Apr; 31(2):143-6. PubMed ID: 7927437
[TBL] [Abstract][Full Text] [Related]
38. Preclinical toxicologic studies of netilmicin.
Weinberg EH; Field WE; Gray WD; Klein MF; Robbins GR; Schwartz E
Arzneimittelforschung; 1981; 31(5):816-22. PubMed ID: 7196743
[TBL] [Abstract][Full Text] [Related]
39. DRF 2655: a unique molecule that reduces body weight and ameliorates metabolic abnormalities.
Vikramadithyan RK; Hiriyan J; Suresh J; Gershome C; Babu RK; Misra P; Rajagopalan R; Chakrabarti R
Obes Res; 2003 Feb; 11(2):292-303. PubMed ID: 12582227
[TBL] [Abstract][Full Text] [Related]
40. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
